SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001370053-20-000007
Filing Date
2020-03-02
Accepted
2020-03-02 08:49:54
Documents
15
Period of Report
2020-03-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K anab-q4198xk.htm   iXBRL 8-K 38228
2 EXHIBIT 99.1 q419earningsrelease.htm EX-99.1 138278
  Complete submission text file 0001370053-20-000007.txt   336410

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anab-20200303.xsd EX-101.SCH 4588
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT anab-20200303_cal.xml EX-101.CAL 624
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anab-20200303_def.xml EX-101.DEF 1474
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT anab-20200303_lab.xml EX-101.LAB 27263
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anab-20200303_pre.xml EX-101.PRE 14114
9 EXTRACTED XBRL INSTANCE DOCUMENT anab-q4198xk_htm.xml XML 4481
Mailing Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO, INC (Filer) CIK: 0001370053 (see all company filings)

IRS No.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37985 | Film No.: 20674336
SIC: 2834 Pharmaceutical Preparations